You are here

R&D

BMS, Avidity add another link to cardiovascular partnership with $100M expansion

Fierce Biotech

Tue, 11/28/23 - 10:29 am

Bristol Myers Squibb

Avidity Biosciences

cardiovascular disease

Can This Pharma CEO Change The Way Drugs Are Discovered, Developed, And Delivered With AI?

Forbes

Wed, 11/8/23 - 10:16 am

Mediar gets a spark from Pfizer’s Ignite scheme as lead fibrosis programs progress

Fierce Biotech

Wed, 10/25/23 - 10:49 pm

Mediar Therapeutics

Giant sloths and woolly mammoths: Mining past creatures’ DNA for future antibiotics

Stat

Wed, 10/25/23 - 09:50 am

Elektrofi and Lilly Enter Multi-Target Research Collaboration and License Agreement

BioSpace

Tue, 10/24/23 - 09:56 am

For women’s health, Organon changed the financial language

Pharma Voice

Wed, 10/18/23 - 10:11 am

sustainable financing

Massachusetts Biopharma Job Growth Surpasses that of Other States: Report

BioSpace

Thu, 10/12/23 - 11:42 am

Largest dataset of thousands of proteins a landmark step for research into human health

Medical Xpress

Fri, 10/6/23 - 11:49 am

Pharma Proteomics Project

Nobel Prize goes to scientists who made mRNA COVID vaccines possible

NPR

Mon, 10/2/23 - 10:18 am

Biden plans $100 million drive to combat drug-resistant 'superbugs'

Reuters

Wed, 09/27/23 - 10:11 am

drug-resistant bacteria

Novo Nordisk and Valo to research cardiometabolic treatments

Reuters

Mon, 09/25/23 - 10:16 am

artificial intelligence

cardiometabolic diseases

Chan Zuckerberg Initiative is building an expensive new AI GPU cluster for medical research

The Verge

Wed, 09/20/23 - 08:45 am

Mark Zuckerberg

artificial intelligence

DeepMind’s New AI Can Predict Genetic Diseases

Wired

Tue, 09/19/23 - 10:59 am

artificial intelligence

Bristol Myers plans to double experimental treatments to expand research pipeline

Yahoo/Reuters

Thu, 09/14/23 - 11:19 am

Bristol Myers Squibb

clinical trials

Gilead-backed study warns IRA price negotiations could hit R&D harder than expected

Fierce Biotech

Wed, 09/6/23 - 11:40 am

Gilead Sciences

Inflation Reduction Act

Sanofi appoints a venture investor to R&D head as executive team expands

BioPharma Dive

Thu, 08/31/23 - 06:05 pm

Houman Ashrafian

AI Is Game Changer For Toughest Areas Of Drug Discovery

Forbes

Thu, 08/31/23 - 11:45 am

artificial intelligence

J&J ends R&D at Janssen's infectious disease and vaccine unit

Fierce Biotech

Wed, 08/23/23 - 05:40 pm

infectious disease

Foundery, a new biotech venture firm, sets out to speed early immune drug research

BioPharma Dive

Tue, 08/22/23 - 09:42 am

venture capital

Pages